98%
921
2 minutes
20
Nucleotide-binding leucine-rich repeat receptors (NLR) are an essential component of plant immunity. NLR evolution is complex and dynamic, with rapid expansions, contractions, and polymorphism. Hundreds of high-quality plant genomes generated over the last 2 decades provide substantial insight into the evolutionary dynamics of NLR genes. Despite steadily decreasing sequencing costs, the difficulty of sequencing, assembling, and annotating high-quality genomes has resulted in comparatively little genome-wide information on intraspecies NLR diversity in long-lived perennial species. In this study, we investigated the evolution of NLR genes across 11 high-quality genomes of the chocolate tree, Theobroma cacao L. We found 3-fold variation in NLR copy number across genotypes, a pattern driven primarily by expansion of NLR clusters via tandem and proximal duplication. Our results indicate local duplications can radically reshape gene families over short evolutionary time scales, creating extensive intraspecific variation and a source of NLR diversity that could be utilized to enrich our understanding of both plant-pathogen interactions and resistance breeding.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12405883 | PMC |
http://dx.doi.org/10.1093/g3journal/jkaf147 | DOI Listing |
Front Immunol
September 2025
Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Background: Cryopyrin-associated periodic syndrome (CAPS) is an autoinflammatory disease caused by a gain-of-function mutation in the gene, which regulates inflammasome-mediated interleukin-1β (IL-1β) production. This leads to recurrent episodes of fever, rash, and arthritis, typically beginning in childhood.
Objective: To demonstrate the role of a missense mutation, c.
Cureus
August 2025
Department of Urology, Graduate School of Medicine, Yamaguchi University, Ube, JPN.
Introduction Currently, treatment regimens incorporating immune checkpoint inhibitors (ICIs) are the standard of care for locally advanced or metastatic urothelial carcinoma (la/mUC). This study aimed to investigate the association between the neutrophil-to-eosinophil ratio (NER) and the occurrence of immune-related adverse events (irAEs) as well as treatment outcomes. Methods This multicenter retrospective study examined patients with la/mUC treated with ICIs between January 2017 and December 2022.
View Article and Find Full Text PDFCureus
August 2025
Department of Paediatrics, All India Institute of Medical Sciences, Raebareli, Raebareli, IND.
Introduction: Early recognition of pediatric sepsis is crucial for timely intervention, prevention of mortality, and improving long-term outcomes in children. However, the lack of advanced diagnostics in resource-limited settings poses a significant challenge to early diagnosis and intervention. Complete blood count (CBC) parameters are routinely performed, cost-effective, and readily available, yet their diagnostic utility in pediatric sepsis remains underutilized.
View Article and Find Full Text PDFAlpha Psychiatry
August 2025
Department of Mental Health, The Second Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
Background: Obesity and depressive disorders are significant public health concerns, and their association is well-documented. This study investigates the role of inflammatory markers, specifically C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR), in mediating the relationship between obesity and depressive symptoms.
Methods: We utilized data from 37,538 adults from the National Health and Nutrition Examination Survey (NHANES), covering the period from 2005 to March, 2020, pre-pandemic.
Rev Bras Ortop (Sao Paulo)
June 2025
Department of Orthopedics and Traumatology, Faculty of Medicine, Udayana University, Prof. Ngoerah General Hospital, Bali, Indonesia.
Objective: The present study explores the association between these inflammatory markers and metastasis in osteosarcoma patients.
Methods: We conducted a retrospective analysis of osteosarcoma patients at our center between January 2022 and August 2024. We collected the clinical and laboratory data of the patients, including white blood cell differential count, C-reactive protein (CRP) levels, erythrocyte sedimentation rate (ESR), neutrophil-to-lymphocyte ratio (NLR), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) levels.